WHO ICTRP trial
EVALUATION OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNOTHERAPY (BELTAVAC®)…
CTIS2024-516893-31-01 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2024-516893-31-01 |
|---|---|
| Public title | EVALUATION OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNOTHERAPY (BELTAVAC®) WITH POLYMERIZED ALLERGENIC EXTRACT OF HOUSE DUST MITE MIXTURE IN PATIENTS WITH ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS |
| Scientific title | EVALUATION OF THE EFFICACY AND SAFETY OF SUBCUTANEOUS IMMUNOTHERAPY (BELTAVAC®) WITH POLYMERIZED ALLERGENIC EXTRACT OF HOUSE DUST MITE MIXTURE IN PATIENTS WITH ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS - PRO-RCT-ACAROS-2018 |
| Primary sponsor | Probelte Pharma S.L. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Spain |
| Conditions | Allergic rhinoconjunctivitis due to exposure of house dust mites MedDRA version: 20.0Level: LLTClassification code: 10020419Term: House dust mite allergy Class: 10021428;Therapeutic area: Diseases [C] - Disorders of Environmental Origin… |
| Interventions | Product Name: Beltavac Polymerized placebo. It is a saline solution without the allergenic extract, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength: , Pharmaceutical form of the placebo: N/A , Product… |
| Registration date | Sep 10, 2024 |
| Target size | 250 |
| Secondary IDs | NCT05395689;2018-003427-11;2018-003427-11 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: